All In Biotech

Drug Trial Radar · NCT00346216

Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen

A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen

Last checked: Nov 19, 2026Latest source record: Mar 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 24,081 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

24,081

Actual

Start

Oct 4, 2006

Primary completion

Apr 12, 2016

Study completion Apr 12, 2016

Sponsor

Sponsor type
Industry
Collaborators
The Cleveland Clinic
First posted
Jun 29, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To answer the question of overall benefit: risk of celecoxib when compared to two most commonly prescribe traditional (non-selective) nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of arthritis pain. For this purpose, patients with osteoarthritis or rheumatoid arthritis with or at risk of developing cardiovascular disease will be recruited. The cardiovascular, gastrointestinal and renal safety and symptomatic benefit in each treatment group will be assessed accordingly.

Conditions

  • Arthritis, Rheumatoid

Interventions

  • celecoxibDrug

    100 to 200 mg twice daily, taken by mouth

  • IbuprofenDrug

    ibuprofen 600 mg to 800 mg three times daily, taken by mouth

  • NaproxenDrug

    naproxen 375mg to 500 mg twice daily, taken by mouth

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The First Occurrence of Antiplatelet Trialists Collaboration (APTC) Composite Endpoint, Confirmed by the Clinical Events Committee (CEC).Time frame: Intent to Treat (ITT) Population - 30 months; Modified ITT (MITT) Population - 42 months

Locations

1,066 sites in 13 countries. Site status is shown where the registry gives one.

  • Carol M. Johnson MD, LLC

    Alabaster, Alabama

  • Orthopaedics West

    Bessemer, Alabama

  • Central Alabama Research

    Birmingham, Alabama

  • Simon Williamson Clinic/Clinical Research Advantage, Inc.

    Birmingham, Alabama

  • Achieve Clinical Research, LLC

    Birmingham, Alabama

  • Alabama Clinical Therapeutics, LLC

    Birmingham, Alabama

  • Cahaba Research Inc.

    Birmingham, Alabama

  • Winston Technology Inc.

    Haleyville, Alabama

  • Clinical Research Consultants, Inc

    Hoover, Alabama

  • Medical Affiliated Research Center, Incorporated

    Huntsville, Alabama

  • Rheumatology Associates of North Alabama, PC

    Huntsville, Alabama

  • Montgomery Rheumatology Associates

    Montgomery, Alabama

  • James P. Beretta, PC

    Pelham, Alabama

  • Alabama Clinical Research Associates

    Pell City, Alabama

  • Pell City Internal and Family Medicine

    Pell City, Alabama

  • Scottsboro Quick Care Clinic

    Scottsboro, Alabama

  • Clinic for Rheumatic Diseases

    Tuscaloosa, Alabama

  • Terence T. Hart , MD

    Tuscumbia, Alabama

  • Clinical Research Advantage Inc./ Warner Family Practice, PC

    Chandler, Arizona

  • ArthroCare, Arthritis Care & Research P.C.

    Gilbert, Arizona

  • Clinical Research Advantage Inc., /Thunderbird Internal Medicine

    Glendale, Arizona

  • Arizona Center for Clinical Research

    Glendale, Arizona

  • Clinical Research Advantage, Inc./ Lenzmeier Family Medicine

    Glendale, Arizona

  • Clinical Research Advantage, Inc./Central Arizona Medical Associates, PC

    Mesa, Arizona

  • Novara Clinical Research

    Mesa, Arizona

  • Clinical Research Advantage, Inc.

    Mesa, Arizona

  • Sun Valley Arthritis Center, Limited

    Peoria, Arizona

  • Lovelace Scientific Resources, Inc.

    Phoenix, Arizona

  • Clinical Research Advantage, Inc./ Family Practice Specialists, LTD

    Phoenix, Arizona

  • NPHC Research

    Phoenix, Arizona

  • Phoenix Clinical

    Phoenix, Arizona

  • Arizona Research Center, Inc.

    Phoenix, Arizona

  • Precision Trials AZ. LLC; AZ

    Phoenix, Arizona

  • 43rd Medical Associates, P.C.

    Phoenix, Arizona

  • Southwest Health Ltd.

    Scottsdale, Arizona

  • Advanced Arthritis Care and Research

    Scottsdale, Arizona

  • Arizona Pain Specialist, PLLC

    Scottsdale, Arizona

  • Sonora Quest Laboratories

    Scottsdale, Arizona

  • Cochise Clinical Research

    Sierra Vista, Arizona

  • Clinical Research Advantage, Inc./Skyline Medical Center PC

    Tempe, Arizona

Showing 40 of 1,066 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.